Major trial tests new mpox vaccine for vulnerable groups
⭐️ VACCINE ⭐️
Ongoing
This large study is testing whether the LC16m8 vaccine is safe and effective at preventing mpox infection. It involves 8,686 adults in Colombia who are at high risk for mpox, including men who have sex with men and people living with HIV. Participants are randomly assigned to rec…
Phase: PHASE3 • Sponsor: Universidad Nacional de Colombia • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:15 UTC